Clover Health Investments, Corp. (CLOV) Revenue, Earnings & Financial Statements
$4.93NASDAQ: CLOVMarket Cap $2.62B
Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Clover Health Investments, Corp. most recently reported annual revenue of $1.9B, a net loss of $86.0M. Revenue grew at an average annual rate of 23.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Clover Health Investments, Corp.: Revenue rose from $281.0M in 2018 to $1.9B in 2025, a change of +584.7% over 7 years; net profit was positive in 0 of 8 reported years; operating margin moved from -66.1% to -4.4%, a shift of +61.7 percentage points; the most recent year shows a net loss of $86.0M.
Income Statement — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
$281.0M
$462.0M
$673.0M
$1.5B
$1.1B
$1.3B
$1.4B
$1.9B
Operating Expenses
$467.0M
$645.0M
$766.0M
$2.1B
$1.4B
$1.5B
$1.4B
$2.0B
Operating Profit
−$186.0M
−$183.0M
−$93.0M
−$637.0M
−$287.0M
−$205.0M
−$46.0M
−$86.0M
Operating Margin
-66.1%
-39.6%
-13.8%
-43.3%
-26.1%
-16.3%
-3.3%
-4.4%
Other Income
−$16.0M
−$181.0M
−$44.0M
$49.0M
$32.0M
−$5.0M
−$1.0M
$0
Interest
$0
$39.0M
$57.0M
$17.0M
$1.0M
$0
$0
$0
Depreciation
$0
$1.0M
$1.0M
$1.0M
$1.0M
$3.0M
$1.0M
$2.0M
Profit Before Tax
−$202.0M
−$364.0M
−$136.0M
−$588.0M
−$255.0M
−$210.0M
−$46.0M
−$86.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Net Profit
−$202.0M
−$364.0M
−$136.0M
−$588.0M
−$340.0M
−$213.0M
−$43.0M
−$86.0M
EPS
−$4.81
−$0.90
−$0.23
−$1.25
−$0.71
−$0.45
−$0.09
−$0.17
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$510.0M
$347.0M
$356.0M
$331.0M
$337.0M
$462.0M
$478.0M
$497.0M
$488.0M
$749.0M
$743.0M
$759.0M
Operating Expenses
$576.0M
$370.0M
$349.0M
$340.0M
$358.0M
$464.0M
$488.0M
$521.0M
$537.0M
$722.0M
$715.0M
$753.0M
Operating Profit
−$66.0M
−$23.0M
$7.0M
−$9.0M
−$21.0M
−$1.0M
−$11.0M
−$24.0M
−$49.0M
$27.0M
$28.0M
$6.0M
Operating Margin
-12.9%
-6.5%
2.0%
-2.6%
-6.4%
-0.3%
-2.2%
-4.9%
-10.1%
3.6%
3.8%
0.8%
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
−$70.0M
−$23.0M
$7.0M
−$9.0M
−$21.0M
−$1.0M
−$11.0M
−$24.0M
−$49.0M
$27.0M
$28.0M
$6.0M
Tax rate (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Net Profit
−$70.0M
−$19.0M
$7.0M
−$9.0M
−$22.0M
−$1.0M
−$11.0M
−$24.0M
−$49.0M
$27.0M
$28.0M
$6.0M
EPS
−$0.15
−$0.04
$0.01
−$0.02
−$0.04
$0.00
−$0.02
−$0.05
−$0.10
$0.05
$0.05
$0.01
Over the 8 years reported for Clover Health Investments, Corp., borrowings decreased from $49.0M in 2018 to $0 in 2025, cash stood at $78.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.47 times.
Balance Sheet — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
$211.0M
$0
$267.0M
$951.0M
$809.0M
$571.0M
$581.0M
$541.0M
Current Assets
$75.0M
$0
$190.0M
$753.0M
$625.0M
$428.0M
$343.0M
$308.0M
Cash
$75.0M
$0
$92.0M
$300.0M
$104.0M
$116.0M
$195.0M
$78.0M
Inventory
$0
$0
$0
$0
$0
$0
$0
$0
Receivables
$0
$0
$85.0M
$109.0M
$168.0M
$86.0M
$93.0M
$159.0M
Fixed Assets
$3.0M
$0
$10.0M
$8.0M
$10.0M
$5.0M
$5.0M
$6.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$59.0M
$491.0M
$369.0M
$241.0M
$229.0M
$204.0M
Other Assets
$0
$0
$0
$0
$12.0M
$0
$0
$0
Total Liabilities
$265.0M
$0
$880.0M
$411.0M
$452.0M
$284.0M
$240.0M
$232.0M
Current Liabilities
$6.0M
$0
$164.0M
$373.0M
$432.0M
$261.0M
$214.0M
$209.0M
Borrowings
$49.0M
$0
$138.0M
$28.0M
$6.0M
$5.0M
$0
$0
Other Liabilities
$216.0M
$0
$742.0M
$384.0M
$446.0M
$280.0M
$240.0M
$232.0M
Equity
$0
$0
$0
$0
$0
$0
$0
$0
Reserves
−$55.0M
$0
−$617.0M
$535.0M
$357.0M
$286.0M
$341.0M
$309.0M
For Clover Health Investments, Corp., operating cash flow was positive in 1 of 8 reported years; free cash flow in the latest year was negative at $69.0M; free cash flow was positive in 1 of 8 years; financing activities used $55.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 8 Years (USD millions)
Metric
2018
2019
2020
2021
2022
2023
2024
2025
Operating Cash Flow
−$153.0M
−$160.0M
−$118.0M
−$282.0M
−$204.0M
−$116.0M
$35.0M
−$67.0M
Investing Cash Flow
$96.0M
−$182.0M
$141.0M
−$436.0M
$91.0M
$139.0M
−$1.0M
$2.0M
Financing Cash Flow
$45.0M
$0
−$1.0M
$666.0M
−$6.0M
−$35.0M
−$18.0M
−$55.0M
Net Cash Flow
$19.0M
−$8.0M
$92.0M
$208.0M
−$114.0M
−$10.0M
$18.0M
−$116.0M
Free Cash Flow
−$155.0M
−$160.0M
−$119.0M
−$283.0M
−$208.0M
−$116.0M
$33.0M
−$69.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
1.37
EV / EBITDA
161.24
FCF Yield
5.06%
Quick Ratio
1.55
Interest Coverage
—
Return 1Y
100.81%
Return 3Y
391.09%
Return 5Y
-31.22%
Clover Health Investments, Corp. (CLOV) financials — frequently asked questions
What is Clover Health Investments, Corp.'s annual revenue?
Clover Health Investments, Corp. (CLOV) reported annual revenue of $1.9B in its most recent fiscal year.
What is Clover Health Investments, Corp.'s net profit?
Clover Health Investments, Corp. (CLOV) reported a net loss of $86.0M in its most recent fiscal year.
What is CLOV EV/EBITDA?
Clover Health Investments, Corp.'s enterprise value to EBITDA (EV/EBITDA) ratio is 161.24.
Revenue and earnings of other Medical - Healthcare Plans stocks